Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 268

1.

Effects of fluvastatin treatment on lipid profile, C-reactive protein trend, and renal function in dyslipidemic patients with chronic renal failure.

Di Lullo L, Addesse R, Comegna C, Firmi G, Galderisi C, Iannacci GR, Polito P.

Adv Ther. 2005 Nov-Dec;22(6):601-12.

PMID:
16510377
[PubMed - indexed for MEDLINE]
2.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.

Clin Ther. 2001 Feb;23(2):177-92.

PMID:
11293552
[PubMed - indexed for MEDLINE]
4.

Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.

Isaacsohn JL, LaSalle J, Chao G, Gonasun L.

Clin Ther. 2003 Mar;25(3):904-18.

PMID:
12852707
[PubMed - indexed for MEDLINE]
5.
6.

Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study).

Ilerigelen B, Uresin Y, San M, Kültürsay H, Güneri S, Serdar OA, Güleç S, Pençedemir H; TULIPS Investigators.

Curr Med Res Opin. 2007 May;23(5):1093-102.

PMID:
17519076
[PubMed - indexed for MEDLINE]
7.
8.

Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.

Austen JL, Shifrin FA, Bartucci MR, Knauss TC, Schulak JA, Hricik DE.

Ann Pharmacother. 1996 Dec;30(12):1386-9.

PMID:
8968448
[PubMed - indexed for MEDLINE]
9.

Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency.

Lintott CJ, Scott RS, Bremer JM, Shand BI.

Am J Cardiol. 1995 Jul 13;76(2):97A-101A.

PMID:
7604809
[PubMed - indexed for MEDLINE]
10.

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.

Olsson AG, Pauciullo P, Soska V, Luley C, Pieters RE, Broda G, Palacios B; Fluvastatin Study Group.

Clin Ther. 2001 Jan;23(1):45-61.

PMID:
11219479
[PubMed - indexed for MEDLINE]
11.

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.

Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.

Am J Kidney Dis. 2002 Jan;39(1):67-75.

PMID:
11774104
[PubMed - indexed for MEDLINE]
13.

Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.

Peters TK, Muratti EN, Mehra M.

Am J Med. 1994 Jun 6;96(6A):79S-83S.

PMID:
8017471
[PubMed - indexed for MEDLINE]
14.

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.

Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR.

Am J Cardiol. 2008 Feb 15;101(4):490-6. doi: 10.1016/j.amjcard.2007.09.099. Epub 2007 Dec 20.

PMID:
18312764
[PubMed - indexed for MEDLINE]
15.

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.

Davidson MH, Palmisano J, Wilson H, Liss C, Dicklin MR.

Clin Ther. 2003 Nov;25(11):2738-53.

PMID:
14693301
[PubMed - indexed for MEDLINE]
16.

The renal safety profile of fluvastatin: results of a pooled analysis.

Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.

Ren Fail. 2006;28(6):487-92.

PMID:
16928618
[PubMed - indexed for MEDLINE]
17.

Impact of fluvastatin on hyperlipidemia after renal transplantation.

Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.

Transplant Proc. 2004 Sep;36(7):2141-4.

PMID:
15518777
[PubMed - indexed for MEDLINE]
18.

Beneficial effects of fluvastatin on progressive renal allograft dysfunction.

Konstadinidou I, Boletis JN, Perrea D, Triantafyllou A, Filiopoulos V, Stamataki E, Kostakis A, Stathakis ChP.

Transplant Proc. 2003 Jun;35(4):1364-7.

PMID:
12826160
[PubMed - indexed for MEDLINE]
19.

Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal disease.

Yasuda G, Kuji T, Hasegawa K, Ogawa N, Shimura G, Ando D, Umemura S.

Ren Fail. 2004 Jul;26(4):411-8.

PMID:
15462110
[PubMed - indexed for MEDLINE]
20.

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.

Bevilacqua M, Righini V, Barrella M, Vago T, Chebat E, Dominguez LJ.

Adv Ther. 2005 Nov-Dec;22(6):527-42.

PMID:
16510370
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk